Personalized cancer prevention for women

Know your risk. Protect your health.

Cancer can affect anyone—even without a family history. The AnteCancerW test provides a scientifically based analysis of your personal risk for breast, colon, and skin cancer (melanoma), based on your genetic profile. Take control of your health early—simple, safe, and convenient from home.

Your benefits at a glance

• Genetic risk test using a cheek swab – conveniently done at home

• Calculation of your personal polygenic risk for prostate, colorectal cancer, and melanoma

• Personalized recommendations for when and how often you should start preventive screenings

• Specific actions to reduce your cancer risk

• CE-certified, GDPR-compliant, and clinically validated

• Optional video consultation – for personal support or to discuss your results

Who is this test suitable for?

• Recommended for all women aged 35 and older

• Especially useful for women under 50 to detect increased risk early

• Ideal for health-conscious women—with or without a family history of cancer

• Available everywhere – through at-home genetic tests and digital prevention recommendations

What is tested?

The test calculates your risk for three types of cancer using a polygenic risk score (PRS):

• 2803 genetic variants for breast cancer

• 91 variants for colorectal cancer

• 28 variants for skin melanoma

Unlike rare single-gene mutations like BRCA1/2, polygenic risk is based on the interaction of many genetic variants—so your risk may be elevated even without a family history.

The risk assessment also takes into account your age, background, and gender to create a prevention plan tailored to you, including clinical recommendations.

Result: Genetic counseling must be provided verbally, but the patient may waive the verbal counseling if the information is made available in writing. The waiver of verbal counseling or consent to written counseling must be documented.

What does this mean for you?

• Your personal risk score compared to the general female population

• Estimated probability of developing breast cancer, colorectal cancer, or melanoma within the next 10 years

• Specific medical recommendations for prevention and early detection

• A medical report for you and your doctor

Additional important information:

• This test is not a diagnostic procedure.

• A high risk does not guarantee illness – a low risk does not rule it out

• Rare high-risk mutations (e.g. BRCA1, BRCA2) are not included

• Based on UK Biobank data and CE-certified as an IVD in the EU and UK

• The underlying scientific models may evolve as new research becomes available.

Legal & scientific information

In accordance with the German Genetic Diagnostics Act (GenDG), you will receive all legally required information in writing before and after the test.

• Before the test: Written information about the purpose, procedure, and possible results
• After the test: Digital report and personalized prevention plan
• Optional: Personal consultation via video for just €150 – bookable at the following link